ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $594 | -24.6% | 22,100 | 0.0% | 0.02% | -28.6% |
| Q2 2023 | $788 | +61.5% | 22,100 | +15.1% | 0.04% | +40.0% |
| Q1 2023 | $488 | -27.5% | 19,200 | +15.7% | 0.02% | -30.6% |
| Q4 2022 | $673 | -99.9% | 16,600 | 0.0% | 0.04% | +20.0% |
| Q3 2022 | $549,000 | -6.0% | 16,600 | 0.0% | 0.03% | +7.1% |
| Q2 2022 | $584,000 | -41.0% | 16,600 | -22.8% | 0.03% | -24.3% |
| Q1 2022 | $989,000 | -30.6% | 21,500 | 0.0% | 0.04% | -22.9% |
| Q4 2021 | $1,425,000 | +6.2% | 21,500 | 0.0% | 0.05% | +2.1% |
| Q3 2021 | $1,342,000 | -24.6% | 21,500 | 0.0% | 0.05% | -23.0% |
| Q2 2021 | $1,781,000 | +50.0% | 21,500 | +20.1% | 0.06% | +29.8% |
| Q1 2021 | $1,187,000 | -13.5% | 17,900 | 0.0% | 0.05% | -19.0% |
| Q4 2020 | $1,373,000 | +52.6% | 17,900 | -14.4% | 0.06% | +38.1% |
| Q3 2020 | $900,000 | -12.5% | 20,900 | -12.2% | 0.04% | -14.3% |
| Q2 2020 | $1,028,000 | +50.1% | 23,800 | 0.0% | 0.05% | +19.5% |
| Q1 2020 | $685,000 | -37.6% | 23,800 | +37.6% | 0.04% | -10.9% |
| Q4 2019 | $1,097,000 | – | 17,300 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |